News and Trends 7 Feb 2023 Antibody candidate for treating serious liver disease …a new method for limiting the development of fatty liver. For the study, the researchers had access to a drug candidate in the form of an antibody to the protein… February 7, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Sep 2025 10 biotech companies in China you should know about …platforms, QureBio has built a robust pipeline of drug candidates aimed at previously intractable diseases. QureBio’s lead candidate, Q-1802, is a claudin18.2/PD-L1 bispecific antibody that received regulatory clearance to initiate… September 16, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2024 Six bispecific antibody companies you should know about …The bispecific antibody company is currently working with Summit Therapeutics on the development of ivonescimab. The candidate, originally discovered by Akeso, combines the power of immunotherapy through a blockade of… November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A …cash, and the lead asset acquired is a monoclonal antibody for inflammatory bowel disease. July 2024: Sionna Therapeutics, based in the United States, has partnered with AbbVie, also a U.S…. March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies …just recently regarding its relapsed or refractory multiple myeloma bispecific candidate, linvoseltamab, after the FDA rejected its filing for approval for the candidate, issuing a complete response letter due to… September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 …Alchemab Therapeutics (in collaboration with Eli Lilly) Technology: B-cells sequencing Candidates: Multiple antibodies Recent news: Collaboration with Eli Lilly to develop ALS candidates Alchemab Therapeutics is a U.K.-based biopharmaceutical company… January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for …of Washington and Fred Hutchinson Cancer Research Center. In a study, the candidate showed a favorable safety profile, and patients showed encouraging immunological responses. Another clinical candidate of Immunomic is… March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year …therapy that is designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of monoclonal antibodies. This way, the drug can kill auto-antibody producing B cells. The candidate is also being… January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2022 Bio-Rad introduces pioneer antibody discovery platform for therapeutic development …display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using Bio-Rad’s newly developed SpyDisplay selection technology. The Pioneer antibody library is… November 16, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Weekly Roundup 8 Dec 2023 Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer …pan‑immunoglobulin (Ig) G protease sculpting (Sc) enzyme candidate (S-1117) and a PD-1 agonist:Fc gamma receptor IIb selective Dual-cell Bidirectional (DcB) antibody candidate (S-4321). The fundraising will also allow Seismic to… December 8, 2023 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Apr 2025 Seven biotechs to watch in the hepatitis B space …its pipeline when it went public for $110.5 million in May 2021. Bluejay Therapeutics Therapeutic candidate: BJT-778 Technology: monoclonal antibody Recent funding: $182 million series C Another California-based biotech, Bluejay Therapeutics,… April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2023 Eight biotech companies tackling infectious diseases head-on …designation from the EMA, the company looks to submit its candidate for regulatory approval next year. Moreover, Bavarian Nordic has other vaccine candidates in the mix. MVA-BN WEV is being… November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email